Seite wählen

Beitragssuche

Antibody therapy against hereditary Alzheimer’s promising?

Scientists from the Dominantly Inherited Alzheimer's Network (DIAN) led by Stephen Salloway have found in a long-term observational study of 144 Alzheimer's patients with familial disease that recombinant antibodies (gantenerumab and solanezumab) are unlikely to stop...

mehr lesen

Diabetes mellitus in relation to other concomitant diseases

Scientists at the Robert Koch Institute (RKI) and the Central Institute for Statutory Health Insurance in Germany (ZI) conducted a study to determine whether diabetes mellitus is associated with obesity, cardiovascular events, and depression in men and women...

mehr lesen

Pain patients benefit from additional telemedical treatment

The medical director of the Migraine and Headache Clinic in Königstein, Dr. Charly Gaul, is an expert in telemedical support in this field. In an interview, he explains the benefits of combined telemedical treatment of chronic pain patients, which must take equal...

mehr lesen

Personalized medicine revolutionizes lung cancer treatment

Every year, 50,000 people in Germany develop lung cancer, one of the most dangerous types of cancer, which is usually only discovered when it has already metastasized. Every year, 35,000 people die from cancer. Lung cancer is also caused by mutations of healthy cells...

mehr lesen

Long Covid study: SARS-CoV-2 virus may also cause diabetes

An international study of long covid symptoms by the Stanford University School of Medicine in cooperation with scientists from the University of Basel and the University Hospital there fuels the initial suspicion that the SARS-CoV-2 virus not only reduces lung...

mehr lesen

Dutch healthcare system: Germans have the right innovations

The German-Dutch Chamber of Commerce, or DNHK, is initiating a digital meeting of German companies in the field of e-health applications, telemedicine, and automation in the fall so that respected Dutch customers can find out about German products. From September 22...

mehr lesen